Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis

Published:2014-10-20 Issue:1 Volume:3 Page:
ISSN:2047-2994
Container-title:Antimicrobial Resistance and Infection Control
language:en
Short-container-title:Antimicrob Resist Infect Control

Author:

Nathwani Dilip,Raman Gowri,Sulham Katherine,Gavaghan Meghan,Menon Vandana

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health

Link

https://link.springer.com/content/pdf/10.1186/2047-2994-3-32.pdf

Reference83 articles.

1. Chatzinikolaou I, Abi-Said D, Bodey GP, Rolston KV, Tarrand JJ, Samonis G: Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes. Arch Intern Med. 2000, 160: 501-509. 10.1001/archinte.160.4.501.

2. Gaynes R, Edwards JR: Overview of nosocomial infections caused by Gram-negative bacilli. Clin Infect Dis. 2005, 41: 848-854. 10.1086/432803.

3. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK: NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol. 2008, 29: 996-1011. 10.1086/591861.

4. Streit JM, Jones RN, Sader HS, Fritsche TR: Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int J Antimicrob Agents. 2004, 24: 111-118. 10.1016/j.ijantimicag.2003.12.019.

5. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, Moreno R, Lipman J, Gomersall C, Sakr Y, Reinhart K: International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009, 302: 2323-2329. 10.1001/jama.2009.1754.

Cited by 241 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of acquired β-lactamases in Pseudomonas aeruginosa and quantification of their contributions to resistance;Microbiology Spectrum;2024-09-09

2. Ceftazidime-avibactam versus other antimicrobial agents for treatment of Multidrug-resistant Pseudomonas aeruginosa: a systematic review and meta-analysis;Infection;2024-08-24

3. What we can and cannot see from the surveillance for drug-resistant Pseudomonas aeruginosa - Findings from the evaluation of surveillance system for multidrug-resistant P. aeruginosa infections in Japan;2024-08-09

4. Healthcare as a driver, reservoir and amplifier of antimicrobial resistance: opportunities for interventions;Nature Reviews Microbiology;2024-07-24

5. Penicillin-binding protein 3 sequence variations reduce susceptibility of Pseudomonas aeruginosa to β-lactams but inhibit cell division;Journal of Antimicrobial Chemotherapy;2024-07-13